About Careers MedBlog Contact us
Medindia LOGIN REGISTER
Advertisement

Cell Pathway Key to Insulin Resistance in Type 2 Diabetes Identified

by Kathy Jones on February 26, 2011 at 8:38 PM
Font : A-A+

 Cell Pathway Key to Insulin Resistance  in Type 2 Diabetes Identified

The key participants in a molecular pathway that holds therapeutic promise for reducing the severity of type 2 diabetes has been identified by scientists.

Their study looked at the role of adenosine, an immune system signaling molecule, in triggering inflammation, which significantly contributes to insulin resistance.nsulin resistance keeps the body from properly handling sugar and is one of the key factors underlying type 2 diabetes.

Advertisement

"Several previous studies have shown that if you block adenosine signaling, insulin resistance is diminished. However, it wasn't known exactly how the process worked or which cells were directly involved," said senior author and La Jolla Institute scientist Joel Linden.

Linden's team identified the primary cellular players in the adenosine-fueled inflammation cascade that contributes to insulin resistance.
Advertisement

Their study, in animal models, also tested the effectiveness of a recently synthesized adenosine receptor blocker.

"We found that if you use this molecule to selectively block one of the adenosine receptors, insulin resistance is decreased and diabetes gets better," said Linden.

The study led by Linden involved scientists from Pennsylvania State University, the University of Virginia, the La Jolla Institute for Allergy and Immunology and Clinical Data, Inc.

In type 2 diabetes, Linden explained, the ability of insulin to stimulate glucose uptake by the tissues is reduced, an occurrence known as insulin resistance.

"We believe, as do many scientists, that insulin resistance involves macrophages, which are cells of the body that contribute to inflammation," Linden explained.

"We discovered that adenosine stimulates macrophages. The macrophages then release chemicals called cytokines, which are molecules that rev up the immune system. We believe it is the cytokines that cause tissues to become less sensitive to insulin," he said.

By using an adenosine receptor blocker, the team prevented the adenosine from activating the macrophages, according to Linden.

As a result the tissues began to better respond to insulin, which reduces blood sugar levels in diabetic animals.

The findings were published in the February issue of the scientific journal Diabetes.

Source: ANI
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
What's New on Medindia
Diet and Oral Health: The Sugary Connection May Become Sour
World AIDS Day 2022 - Equalize!
Test Your Knowledge on Sugar Intake and Oral Health
View all
Recommended Reading
News Archive
Date
Category
Advertisement
News Category

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Diabetic Retinopathy Diabetes Diabetic Diet Otitis Media Diabetes - Essentials Parkinsons Disease Surgical Treatment Diabetes - Self-Monitoring of Blood Glucose (SMBG) Insulin Delivery Devices Diabetes and Exercise Metabolic Syndrome 

Most Popular on Medindia

Vent Forte (Theophylline) Blood Donation - Recipients Daily Calorie Requirements Loram (2 mg) (Lorazepam) Find a Doctor Find a Hospital Blood - Sugar Chart Diaphragmatic Hernia Hearing Loss Calculator A-Z Drug Brands in India
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close
×

Cell Pathway Key to Insulin Resistance in Type 2 Diabetes Identified Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests